China Money Network
Login
Join

Decheng Capital Leads $45M Series C Round In Chinese Biopharmaceutical Firm KeChow Pharma

  • December 13, 2019 — 11:25 CST

This Data Is Locked!

This area is available only to Subscribers.

Shanghai KeChow Pharma, a Chinese biopharmaceutical company focused on novel drug discover, has raised US$45million in a series C round of financing led by Decheng... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: